Trial
NCT02780882
SOM230 Ectopic ACTH-producing Tumors
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Cedars-Sinai Medical Center
Collaborators
Novartis
Condition
Ectopic ACTH Syndrome
Intervention
Pasireotide
Why stopped
Due to stringent inclusion/exclusion criteria, study investigator deemed it not feasible.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-26